CAI vs CAMP

Caris Life Sciences, Inc. vs CAMP4 THERAPEUTICS CORPORATION — Valuation Comparison 2026

By CirclFi Research Team · Updated 2026-06-03 · Data from SEC EDGAR, FRED & GDELT

Quick Summary — CAMP scores higher on quality with 6.1/10 vs CAI's 6.0/10. CAI trades at $16.52 while CAMP trades at $3.98. Both analyzed daily using SEC EDGAR data across 13 institutional models.

CAI

Biotechnology
Caris Life Sciences, Inc.
Quality
6.0
out of 10
Value Trap
Price
$16.52
Last close
Models
13/13
Active
VS

CAMP

Biotechnology
CAMP4 THERAPEUTICS CORPORATION
Quality
6.1
out of 10
Value Trap
18
SAFE
Price
$3.98
Last close
Models
9/13
Active
CAI
2 models active
Limited to 2/13 visible models
CAMP
2 models active
Limited to 2/13 visible models

CAI vs CAMP — Fair Value Comparison

CAI
$0$6$13$19 Price$16.52 Bayesian …$3.68 (-80.1%) Earnings …$3.21 (-82.6%)
CAMP
$0$2$3$5 Price$3.98 Bayesian …$0.36 (-90.9%) Dynamic N…$1.44 (-64.6%)
Market Price Model 1 Model 2

Model-by-Model Comparison

ModelType CAI Fair ValueCAI Upside CAMP Fair ValueCAMP Upside
Bayesian DCF Intrinsic $3.68 -80.1% $0.36 -90.9%
Earnings Power Value Intrinsic $3.21 -82.6%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
Markov DDM Intrinsic $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $1.25 -93.2% $1.44 -64.6%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
RCMH-DCF Intrinsic $•••.•• ••.•% $•••.•• ••.•%

CAI vs CAMP — Which Stock Is More Undervalued in 2026?

CAMP scores higher with a 6.1/10 quality rating vs CAI's 6.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

How Do CAI and CAMP Valuations Compare?

At $16.52, CAI trades +80.1% above its Bayesian DCF fair value of $3.68, while CAMP at $3.98 trades +90.9% above its estimate of $0.36. CAMP shows a wider gap between price and intrinsic value.

Quality of Company: CAI vs CAMP

CAI earns a Quality of Company score of 6.0/10 compared to CAMP's 6.1/10. The scores are closely matched, indicating similar fundamental quality profiles. The QOC score synthesizes 32 signals spanning profitability margins, revenue growth, free cash flow, capital allocation, and leverage.

Value Trap Risk: CAI vs CAMP

Review the value trap analysis for both CAI and CAMP to assess whether apparent undervaluation reflects genuine opportunity or hidden fundamental risk.

Both in Biotechnology

Both CAI and CAMP operate in Biotechnology, which has 566 stocks tracked by CirclFi. Same-industry comparisons provide the most direct insight into relative valuation since both companies face similar regulatory environments, market dynamics, and competitive pressures. Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN), and ensemble methods (CUCE).

2 of 13 MODELS UNLOCKED

You’re comparing 2 models. 11 more have an opinion.

11 hidden models compare CAI vs CAMP differently — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more. Some may disagree with the 2 you see above.

11 additional fair values per stock Full confidence breakdown Live terminal — 5,000+ stocks

Bloomberg Terminal: ~$2,000/mo  ·  FactSet: ~$1,000/mo  ·  CirclFi: $0.90/day

See All 13 Models — $0.90/day

We don’t predict prices. We show you what 13 independent mathematical frameworks say a stock is worth — and let you decide.

See all Biotechnology stocks →